Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NG25 是TAK1(IC50:149 nM)和MAP4K2(IC50:21.7 nM)的双抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 633 | 现货 | ||
2 mg | ¥ 932 | 现货 | ||
5 mg | ¥ 1,790 | 现货 | ||
10 mg | ¥ 2,680 | 现货 | ||
25 mg | ¥ 4,430 | 现货 | ||
50 mg | ¥ 6,250 | 现货 | ||
100 mg | ¥ 8,420 | 现货 | ||
500 mg | ¥ 16,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,170 | 现货 |
产品描述 | NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively. |
靶点活性 | MAP4K2:21.7 nM, TAK1:149 nM |
体外活性 | NG25 sensitizes the breast cancer cells to Dox treatment in vitro. This combination may be an effective and feasible therapeutic option maximizing Dox efficacy and meanwhile minimizing Dox side effects in treating breast cancer[1]. |
细胞实验 | Breast cancer cells were seeded in 12-well plates at 2?×?10^3 cells per well, then incubated with Dox alone or Dox with NG25 at indicated concentrations after 72?h and then were cultured in fresh medium without drug.?Two weeks later, cells were fixed and stained with methanol/crystal violet for 10?min, and photographed.?Each experiment was performed in triplicates[1]. |
分子量 | 537.58 |
分子式 | C29H30F3N5O2 |
CAS No. | 1315355-93-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (186.02 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8602 mL | 9.3009 mL | 18.6019 mL | 46.5047 mL |
5 mM | 0.372 mL | 1.8602 mL | 3.7204 mL | 9.3009 mL | |
10 mM | 0.186 mL | 0.9301 mL | 1.8602 mL | 4.6505 mL | |
20 mM | 0.093 mL | 0.465 mL | 0.9301 mL | 2.3252 mL | |
50 mM | 0.0372 mL | 0.186 mL | 0.372 mL | 0.9301 mL | |
100 mM | 0.0186 mL | 0.093 mL | 0.186 mL | 0.465 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NG25 1315355-93-1 MAPK NG-25 NG 25 MAP kinase kinase kinase, MEKK, MAPKKK MAP4K inhibit Inhibitor MAP3K MAPK Kinase Kinase Kinase inhibitor